J. Charlesworth

发表

Complement inhibition by human vitronectin involves non‐heparin binding domains

M. Sheehan, C. A. Morris, B. Pussell, 1995, Clinical and experimental immunology.

Successful treatment of acute dapsone intoxication using charcoal hemoperfusion.

Z. Endre, G. Macdonald, J. Charlesworth, 1983, Australian and New Zealand journal of medicine.

Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves.

J. Lieske, G. Rodgers, V. Miller, 2004, American journal of physiology. Heart and circulatory physiology.

The postprandial response of adiponectin to a high-fat meal in normal and insulin-resistant subjects

L. Campbell, A. Kriketos, G. Denyer, 2003, International Journal of Obesity.

Insulin resistance and postprandial triglyceride levels in primary renal disease.

L. Campbell, J. Erlich, A. Kriketos, 2005, Metabolism: clinical and experimental.

Lipoprotein lipids in chronic renal failure and haemodialysis. The influence of etiology and implications for atherogenesis.

G. Macdonald, J. M. Aitken, J. Somer, 1979, Atherosclerosis.

Review Article: Adiponectin: Its role in kidney disease

P. Peake, Yvonne Y Shen, J. Charlesworth, 2008, Nephrology.

Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: A multicentre, open‐label, Australian study

D. Harris, M. Gallagher, A. Disney, 2007, Nephrology.

Outcome of overseas commercial kidney transplantation: an Australian perspective

J. Mahony, B. Pussell, S. Kennedy, 2005, The Medical journal of Australia.

Expression of mesangial IgA nephropathy in a family with several HLA‐dentical members

M. Brown, B. Pussell, J. Charlesworth, 1998 .

Importance of renal biopsy *

J. Charlesworth, C. Nelson, M. Mackinnon, 2001 .

Association of acute leukaemia with chlorambucil after renal transplantation

G. Macdonald, B. Pussell, J. Charlesworth, 1994, The Lancet.

THE SKIN AND IMMUNOSUPPRESSION *

G. Macdonald, B. Pussell, J. Charlesworth, 1976, The Australasian journal of dermatology.

HOME HÆMODIALYSIS AS PART OF A COMPREHENSIVE RENAL REPLACEMENT PROGRAMME

E. Gallery, J. Hayes, D. Tiller, 1973, The Medical journal of Australia.

The effect of renal transplantation on adiponectin and its isoforms and receptors.

P. Peake, Yvonne Y Shen, J. Kelly, 2007, Metabolism: clinical and experimental.

The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals.

L. Campbell, A. Kriketos, P. Peake, 2005, European journal of endocrinology.

Electron microscopic and immunological evidence of nanobacterial-like structures in calcified carotid arteries, aortic aneurysms, and cardiac valves

G. Rodgers, V. Miller, T. Rasmussen, 2002 .

Adiponectin binds C1q and activates the classical pathway of complement.

P. Peake, Yvonne Y Shen, J. Charlesworth, 2008, Biochemical and biophysical research communications.

The inhibitory effect of rosmarinic acid on complement involves the C5 convertase.

B. Pussell, P. Peake, J. Charlesworth, 1991, International journal of immunopharmacology.

Adiponectin is present in the urine in its native conformation, and specifically reduces the secretion of MCP‐1 by proximal tubular cells

P. Peake, Yvonne Y Shen, J. Kelly, 2008, Nephrology.

Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease.

P. Peake, Yvonne Y Shen, J. Kelly, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Glycosylation of human adiponectin affects its conformation and stability.

P. Peake, Yvonne Y Shen, J. Charlesworth, 2007, Journal of molecular endocrinology.

The detection of immune complexes of different immunoglobulin class.

G. Macdonald, J. Charlesworth, J. Quin, 1979, Australian and New Zealand journal of medicine.

The kinetics and distribution of C9 and SC5b‐9 in vivo: effects of complement activation

P. Peake, J. Charlesworth, J. Greenstein, 1995, Clinical and experimental immunology.

The development of cardiac fibrosis in low tissue factor mice is gender-dependent and is associated with differential regulation of urokinase plasminogen activator.

N. Mackman, J. Erlich, S. Kennedy, 2007, Journal of Molecular and Cellular Cardiology.

The Role of Mesangial Cells in Glomerular Pathology

D. Wakefield, N. Hawkins, J. Charlesworth, 1990, Pathology.

COMPLEMENT ACTIVATION IN MIGRAINE

J. Charlesworth, G. Lord, T. W. Duckworth, 1977, The Lancet.

Detection of lymphocytotoxic antibodies in relatives of patients with type I diabetes.

L. Campbell, B. Pussell, P. Peake, 1986, British medical journal.

Vasculitic renal disease *

B. Pussell, J. Charlesworth, M. Mackinnon, 2002 .

Acute Kidney Injury in Severe COVID-19 Has Similarities to Sepsis-Associated Kidney Injury

A. Rule, A. Pandey, A. Madugundu, 2021, Mayo Clinic Proceedings.

Angiotensin II receptor regulation in anti-glomerular basement membrane nephritis.

G. Macdonald, P. Peake, J. Charlesworth, 1990, Kidney international.

Association of complement allotype C4B2 with anterior uveitis.

D. Wakefield, P. McCluskey, B. Pussell, 1988, Human immunology.

Immune complexes in diabetes mellitus.

L. Campbell, G. Macdonald, L. Lazarus, 1979, Australian and New Zealand journal of medicine.

Sensory nerve excitability and neuropathy in end stage kidney disease

M. Kiernan, B. Pussell, R. Phoon, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor.

B. Pussell, P. Peake, S. O’Grady, 1999, Kidney international.

Human fibronectin metabolism.

M. Brown, B. Pussell, P. Peake, 1985, The Journal of clinical investigation.

The Nail Patella syndrome--a report of a family.

G. Macdonald, B. Pussell, J. Charlesworth, 1977, Australian and New Zealand journal of medicine.

Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis.

P. Lachmann, D. Peters, J. Charlesworth, 1973, Lancet.

Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease

M. Kiernan, H. Bostock, B. Pussell, 2006, Clinical Neurophysiology.

The effect of pH and nucleophiles on complement activation by human proximal tubular epithelial cells

B. Pussell, P. Peake, B. Mackinnon, 2002 .

Is control of hyperlipidaemia important in kidney transplantation?

J. Charlesworth, K. Edwards, 1973, Lancet.

Complement deficiency and disease.

B. Pussell, J. Charlesworth, 1982, Australian and New Zealand journal of medicine.

Goodpasture's (anti-GBM) disease and HLA-DRw2.

G. Macdonald, B. Pussell, J. Charlesworth, 1981, The New England journal of medicine.

Adult nephrotic syndrome: Non‐specific strategies for treatment (Review Article)

B. Pussell, D. Gracey, J. Charlesworth, 2008, Nephrology.

The complement system in infectious mononucleosis.

B. Pussell, S. Lawrence, J. Charlesworth, 1977, Australian and New Zealand journal of medicine.

Activation of rabbit C3: studies of the generation of cleavage products in vitro and of their metabolism in vivo.

B. Pussell, P. Peake, J. Charlesworth, 1991, Complement and inflammation.

Vitronectin‐mediated inhibition of complement: evidence for different binding sites for C5b‐7 and C9

B. Pussell, M. Sheehan, C. A. Morris, 1993, Clinical and experimental immunology.

ANCA‐positive vasculitis induced by thioridazine: confirmed by rechallenge

J. Greenfield, L. Campbell, S. Kossard, 2002, The British journal of dermatology.

Complement, lymphocytotoxins and immune complexes in infectious mononucleosis: serial studies in uncomplicated cases.

G. Macdonald, J. Charlesworth, C. Boughton, 1978, Clinical and experimental immunology.

Community treatment of end-stage renal failure by dialysis and renal transplantation from cadaver donors.

J. Loewenthal, A. Sheil, J. Johnson, 1969, Lancet.

Relative topography of biologically active domains of human vitronectin. Evidence from monoclonal antibody epitope and denaturation studies.

C. Morris, P. Underwood, P. Bean, 1994, The Journal of biological chemistry.

Significance of sequential changes in serum complement levels during acute anaphylactoid reactions

M. Fisher, J. Charlesworth, B. Teisnner, 1984, Critical Care Medicine.

Controlled clinical trial of antilymphocyte globulin in patients with renal allografts from cadaver donors.

A. Sheil, J. Johnson, J. Charlesworth, 1971, Lancet.

Evaluation of cadaver-donor renal transplantation.

A. Sheil, J. Johnson, J. Charlesworth, 1971, Transplantation proceedings.

CADAVERIC DONOR RENAL TRANSPLANTATION

D. Tiller, J. Mahony, J. Johnson, 1972, The Medical journal of Australia.

Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.

P. Lachmann, D. Peters, J. Charlesworth, 1974, The Journal of clinical investigation.

Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia.

D. Evans, D. Peters, O. Kourilsky, 1973, Lancet.

Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury.

N. Mackman, J. Erlich, S. Kennedy, 2007, Blood.

Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease.

M. Kiernan, H. Bostock, B. Pussell, 2006, Brain : a journal of neurology.

The effect of pH and nucleophiles on complement activation by human proximal tubular epithelial cells.

B. Pussell, P. Peake, B. Mackinnon, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Factors Influencing Reticulophagocytic Function in Insulin-treated Diabetes

L. Campbell, M. Kotowicz, B. Pussell, 1984, Diabetes.

The complement system in Type 1 (insulin-dependent) diabetes

D. Wakefield, L. Campbell, B. Pussell, 1987, Diabetologia.

Splenic function in primary glomerulonephritis.

B. Pussell, S. Lawrence, J. Charlesworth, 1982, Advances in experimental medicine and biology.

Angiography in the diagnosis of renal allograft dysfunction.

R. M. Williams, G. Macdonald, B. J. Jones, 1978, The Journal of urology.

Human adiponectin binds to bacterial lipopolysaccharide.

L. Campbell, P. Peake, Yvonne Y Shen, 2006, Biochemical and biophysical research communications.

Mesangial IgA nephropathy: detection of defective reticulophagocytic function in vivo.

B. Pussell, S. Lawrence, J. Charlesworth, 1983, Clinical nephrology.

Altered motor nerve excitability in end-stage kidney disease.

M. Kiernan, H. Bostock, B. Pussell, 2005, Brain : a journal of neurology.

Complement in renal disease

J. Erlich, B. Pussell, P. Peake, 2001 .

C3 metabolism in acute glomerulonephritis: implications for sites of complement activation.

H. Coovadia, Z. Endre, B. Pussell, 1984, Kidney international.

Post‐streptococcal glomerulonephritis: studies on the interaction betwen nephritis strain‐associated protein (NSAP), complement and the glomerulus

B. Pussell, P. Peake, J. Charlesworth, 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Complement behavior in infectious mononucleosis: possible mechanisms for the prevention of immune complex injury.

Z. Endre, B. Pussell, P. Peake, 1982, The Journal of infectious diseases.

Metabolism of human beta 1H: studies in man and experimental animals.

D. Scott, B. Pussell, D. Peters, 1979, Clinical and experimental immunology.

Metabolism of the third component of complement (C3) in normal human subjects.

D. Peters, J. Charlesworth, D. G. Williams, 1974, Clinical science and molecular medicine.

Renal involvement in paraquat poisoning.

S. Kew, J. Charlesworth, M. Segasothy, 1984, Nephron.

Detection and quantification of the control proteins of the alternative pathway of complement in 3T3‐L1 adipocytes

B. Pussell, P. Peake, S. O’Grady, 1997, European journal of clinical investigation.

Measles infection. Involvement of the complement system.

B. Pussell, J. Beveridge, J. Charlesworth, 1976, Clinical and experimental immunology.

Complement activation contributes to leukocyte recruitment and neuropathic pain following peripheral nerve injury in rats

D. Tracey, J. Charlesworth, Man Li, 2007, The European journal of neuroscience.

Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects.

J. Greenfield, L. Campbell, A. Kriketos, 2004, Diabetes care.

Lipoprotein lipids in renal transplant recipients of different pre-transplant etiology of renal disease. A comparison of male and female patients.

G. Macdonald, J. M. Aitken, J. Somer, 1981, Atherosclerosis.

The value of complement measurements in the assessment of lupus activity.

C. Morris, B. Pussell, J. Charlesworth, 1992, Australian and New Zealand journal of medicine.

Acute granulomatous tubulointerstitial nephritis caused by intravesical BCG.

S. Kennedy, J. Charlesworth, S. Shrikanth, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes

L. Campbell, A. Kriketos, P. Peake, 2005, International Journal of Obesity.

Reduced cardiac beat-to-beta variation in chronic renal failure: a ubiquitous marker of autonomic neuropathy.

E. Kraegen, Z. Endre, G. Macdonald, 1982, Clinical science.

Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.

D. Wakefield, B. Pussell, P. Peake, 1989, Annals of the Rheumatic Diseases.

The metabolism of C3 and C4 in patients with immune complexes and normal complement levels.

D. Wakefield, B. Pussell, P. Peake, 1989, Australian and New Zealand journal of medicine.

The influence of pre-transplant etiology of renal disease on lipoprotein lipids in female renal allograft receipients.

G. Macdonald, J. M. Aitken, J. Charlesworth, 1980, Atherosclerosis.

Metabolism of radio-labelled C3: effects of in vivo activation in rabbits.

P. Lachmann, P. Naish, D. Peters, 1974, Clinical and experimental immunology.